Harbour Investments Inc. Has $331,000 Stock Holdings in Danaher Co. (NYSE:DHR)

Harbour Investments Inc. decreased its stake in Danaher Co. (NYSE:DHR) by 5.7% in the 4th quarter, Holdings Channel.com reports. The firm owned 1,443 shares of the conglomerate’s stock after selling 88 shares during the quarter. Harbour Investments Inc.’s holdings in Danaher were worth $331,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Heck Capital Advisors LLC bought a new position in Danaher in the 4th quarter valued at approximately $27,000. Decker Retirement Planning Inc. bought a new position in shares of Danaher during the fourth quarter valued at $31,000. Golden State Wealth Management LLC bought a new position in shares of Danaher during the fourth quarter valued at $31,000. Teachers Insurance & Annuity Association of America bought a new position in shares of Danaher during the third quarter valued at $39,000. Finally, Pineridge Advisors LLC raised its stake in shares of Danaher by 63.3% during the fourth quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate’s stock valued at $34,000 after acquiring an additional 57 shares during the last quarter. Institutional investors own 79.05% of the company’s stock.

Wall Street Analyst Weigh In

DHR has been the subject of a number of analyst reports. Citigroup lowered their target price on shares of Danaher from $285.00 to $265.00 and set a “buy” rating for the company in a research note on Thursday, January 30th. StockNews.com downgraded shares of Danaher from a “buy” rating to a “hold” rating in a research note on Saturday, December 14th. Jefferies Financial Group lowered their target price on shares of Danaher from $285.00 to $260.00 and set a “buy” rating for the company in a research note on Wednesday, January 29th. Barclays lowered their target price on shares of Danaher from $275.00 to $240.00 and set an “equal weight” rating for the company in a research note on Thursday, January 30th. Finally, Scotiabank initiated coverage on shares of Danaher in a report on Monday, December 23rd. They issued a “sector perform” rating and a $265.00 price target for the company. Five equities research analysts have rated the stock with a hold rating and seventeen have given a buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $278.24.

Danaher Stock Up 0.7 %

Danaher stock opened at $211.63 on Friday. Danaher Co. has a fifty-two week low of $196.80 and a fifty-two week high of $281.70. The stock has a market cap of $151.26 billion, a PE ratio of 40.08, a price-to-earnings-growth ratio of 2.66 and a beta of 0.82. The firm’s 50-day simple moving average is $217.46 and its 200 day simple moving average is $238.86. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40.

Danaher (NYSE:DHR) last released its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, hitting the consensus estimate of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same quarter in the previous year, the firm earned $2.09 EPS. Research analysts predict that Danaher Co. will post 7.63 EPS for the current fiscal year.

Danaher Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be issued a dividend of $0.32 per share. The ex-dividend date of this dividend is Friday, March 28th. This is a boost from Danaher’s previous quarterly dividend of $0.27. This represents a $1.28 annualized dividend and a yield of 0.60%. Danaher’s payout ratio is 24.24%.

Insider Buying and Selling

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of Danaher stock in a transaction dated Thursday, January 30th. The shares were sold at an average price of $224.13, for a total value of $1,277,541.00. Following the sale, the senior vice president now owns 20,230 shares of the company’s stock, valued at approximately $4,534,149.90. The trade was a 21.98 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. 10.90% of the stock is owned by corporate insiders.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.